Ref ID: 17732
Author:
E. Cendejas-Bueno*, B. Theelen, A. Gómez-López, M. Cuenca-Estrella,
T. Boekhout
Author address:
Majadahonda, ES; Utrecht, NL)
Full conference title:
22nd European Congress of Clinical Microbiology and Infectious Diseases
Abstract:
Background: C. haemulonii is one of the rarest yeast species that can
be isolated from human clinical sources. Fungal infections due to this
yeast have been described in the literature, varying from superficial to
deep infections. Cases of catheter related fungemia, blood stream
infection, osteitis and outbreaks in intensive care units have been
reported recently.
The susceptibility profile of this C. haemulonii shows that is resistant to
Amphotericin B (AMB) and Fluconazole (FLC) with high Minimal
Inhibitory Concentrations (MIC) for both compounds, which can hinder
the management of patients with deep infections caused by this yeast.
This antifungal profile has often been associated with clinical failure.
Materials and methods: Thirty strains of the C. haemulonii complex
belonging to the Mycology Department of the National Centre for
Microbiology (CNM, Majadahonda, Spain) and the CBS Fungal
Biodiversity Centre (CBS-KNAW, Utrecht, The Netherlands)
collections were analyzed. The amplification and sequencing of the
ITS domain (ribosomal DNA), D1/D2 region and DNA Polimerase II
gen (RPB2) were done.
Results: From the 30 isolates of the C. haemulonii complex used in the
present study, 19 were assigned to the most commonly encountered
group (C. haemulonii group I), seven isolates were assigned to C.
haemulonii group II, and the other four Isolates were assigned to a new
cluster. Based on the ITS sequences analysis, three main clusters were
distinguished. The first one included 23 strains, four out of these 23
formed a subcluster of ’’atypical’’ strains which were positive distantly
from the other 19 C. haemulonii group I isolates. The third cluster
included strains that belong to the C. haemulonii group II. On the other
hand, the analysis of the RPB2 gene showed the same results as the
ones showed in the ITS analysis. Whereas the analysis of the D1-D2
26S rRNA gene fragment sequences only showed two different clusters.
The group formed by the four ’’atypical isolates’’ was included in the
same cluster as those of C. haemulonii.
Conclusions: (i) the molecular data of the RPB2, D1/D2 and ITS
regions demonstrate that the C. haemulonii complex has a high
genetic diversity. These data suggest that C. haemulonii complex is
composed by three different clusters. (ii) Due to the resistant
antifungal profile, more studies would be needed in order to
establish a relationship between the susceptibility profile and each
one of these three clusters.
Abstract Number: NULL
Conference Year: 2012
Link to conference website: NULL
New link: NULL
Conference abstracts, posters & presentations
-
Title
Author
Year
Number
Poster
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
81
n/a
-
v
Rose-Anne Lavergne (FR)
2024
79
n/a
-
v
Rutuja H. Patil1, Tereza Juříková1, Andrea Palyzová1, and Vladimír Havlíček1,2
2024
78
n/a
-
v
Rui Xu1-2,, Chuqin Huang1 , Rong Yan1, Yanyan Lou1-2, Bo Zhang1, Yingyi Pan1, Yingying Liu1, Sini Huang1, Zhiyuan Zhang1, Antonin Tidu2, Thorsten Heinekamp3, Philippe Bulet4, Franck Martin2, , Axel Brakhage3, Li Zi1, Samuel Liegeois1-2, Dominique Ferrandon* 1-2
2024
75
n/a
-
v
Dominika Luptáková1, Tereza Hřivnová Juříková 1, Miloš Petřík2, Andrea Palyzová1, Vladimír Havlíček1
2024
74
n/a
-
v
Amer Ali Abd El-Hafeez1, Gabriele Sass2, David A. Stevens2,3, Vladimír Havlíček4,5, Ioly Kotta-Loizou6,7, Joe Hsu1
2024
73
n/a